Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Dermapharm Holding SE (DMP) NPV (Bearer Shares)

Sell:€53.88 Buy:€53.93 Change: €0.1 (0.19%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€53.88
Buy:€53.93
Change: €0.1 (0.19%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:€53.88
Buy:€53.93
Change: €0.1 (0.19%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.

Contact details

Address:
Lil-Dagover-Ring 7
GRUENWALD
82031
Germany
Telephone:
+49 (89) 641860
Website:
https://ir.dermapharm.de/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
DMP
ISIN:
DE000A2GS5D8
Market cap:
€2.91 billion
Shares in issue:
53.84 million
Sector:
Pharmaceuticals
Exchange:
Xetra
Country:
Germany
Currency:
Euro
Indices:
n/a

Key personnel

  • Wilhelm Beier
    Chairman of the Supervisory Board
  • Hans-Georg Feldmeier
    Chairman of the Management Board, Chief Executive Officer
  • Erwin Kern
    Vice Chairman of the Supervisory Board
  • Hilde Neumeyer
    Chief Financial Officer, Member of the Management Board
  • Juergen Ott
    Chief Marketing Officer, Member of the Management Board
  • Karin Samusch
    Member of the Management Board, Chief Business Development Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.